Compare BKR & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKR | A |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.5B | 39.8B |
| IPO Year | N/A | 1999 |
| Metric | BKR | A |
|---|---|---|
| Price | $50.24 | $145.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 15 |
| Target Price | $53.76 | ★ $164.13 |
| AVG Volume (30 Days) | ★ 7.4M | 2.0M |
| Earning Date | 01-25-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.88% | 0.69% |
| EPS Growth | ★ 30.28 | 3.16 |
| EPS | 2.90 | ★ 4.57 |
| Revenue | ★ $27,711,000,000.00 | $6,948,000,000.00 |
| Revenue This Year | N/A | $8.00 |
| Revenue Next Year | $2.99 | $6.29 |
| P/E Ratio | ★ $16.82 | $32.34 |
| Revenue Growth | 1.50 | ★ 6.73 |
| 52 Week Low | $33.60 | $96.43 |
| 52 Week High | $51.12 | $160.27 |
| Indicator | BKR | A |
|---|---|---|
| Relative Strength Index (RSI) | 64.91 | 57.45 |
| Support Level | $48.31 | $135.27 |
| Resistance Level | $50.13 | $149.39 |
| Average True Range (ATR) | 1.04 | 2.53 |
| MACD | 0.57 | 1.26 |
| Stochastic Oscillator | 96.82 | 72.80 |
Following a 2022 reorganization, Baker Hughes operates in two segments: oilfield services and equipment, and industrial and energy technology. The firm's oilfield services and equipment segment is one of the Big Three oilfield-services players, along with SLB and Halliburton, and mostly supplies to hydrocarbon developers and producers, including national oil companies, major integrated firms, and independents. Markets outside of North America buy roughly three-fourths of the segment's offerings. Baker Hughes' industrial and energy technology segment manufactures and sells turbines, compressors, pumps, valves, and related testing and monitoring services for various energy and industrial applications.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.